SAR446959
/ Sanofi
- LARVOL DELTA
Home
Next
Prev
1 to 1
Of
1
Go to page
1
August 16, 2025
A First-in-human Study to Investigate Safety and Tolerability of SAR446959 in Participants With Osteoarthritis of the Knee
(clinicaltrials.gov)
- P1 | N=32 | Active, not recruiting | Sponsor: Sanofi | Recruiting ➔ Active, not recruiting
Enrollment closed • Immunology • Osteoarthritis • Pain • Rheumatology
1 to 1
Of
1
Go to page
1